Comment on ‘Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer’—No support for de-escalation of immunotherapy

2019 ◽  
Vol 115 ◽  
pp. 24-26
Author(s):  
Alexandros Georgiou ◽  
Anna Minchom ◽  
Mary O'Brien
2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7034-7034 ◽  
Author(s):  
M. P. Fanucchi ◽  
F. Fossella ◽  
P. Fidias ◽  
R. B. Natale ◽  
R. J. Belt ◽  
...  

2018 ◽  
Vol 13 (4) ◽  
pp. 576-584 ◽  
Author(s):  
Enriqueta Felip ◽  
Fabrice Barlesi ◽  
Benjamin Besse ◽  
Quincy Chu ◽  
Leena Gandhi ◽  
...  

2019 ◽  
Vol 108 ◽  
pp. 120-128 ◽  
Author(s):  
Benjamin P. Levy ◽  
Giuseppe Giaccone ◽  
Benjamin Besse ◽  
Enriqueta Felip ◽  
Marina Chiara Garassino ◽  
...  

2009 ◽  
Vol 4 (8) ◽  
pp. 1002-1009 ◽  
Author(s):  
Thomas J. Lynch ◽  
David Fenton ◽  
Vera Hirsh ◽  
David Bodkin ◽  
Edward L. Middleman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document